BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion

Hattenbach, Lars‐Olof; Abreu, Francis; Arrisi, Pablo; Basu, Karen; J. Danzig, Carl; H. Guymer, Robyn; Hašková, Zdenka; S. Heier, Jeffrey; Kotecha, Aachal; Liu, Ying; Loewenstein, Anat; Seres, András; R. Willis, Jeffrey; C. Wykoff, Charles; P Paris, Liliana

doi:10.1016/j.xops.2023.100302

Public

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion

Published in Ophthalmology Science • Mar 27, 2023

Authors:

Lars‐Olof Hattenbach

Francis Abreu

Pablo Arrisi

Abstract

PurposeDual inhibition of angiopoietin-2 and VEGF-A with faricimab (Vabysmo) offers excellent visual acuity gains with strong durability in patients with diabetic macular edema (ME) and neovascular age-related macular degeneration. The phase III BALATON/COMINO (NCT04740905/NCT04740931) trials will i...

Subject

Aflibercept

Medicine

Central retinal vein occlusion

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!